Stocktoria
Nuvectis Pharma, Inc. NVCT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2022-02-04
Nuvectis Pharma, Inc. statistics & valuation
Market cap$721.2M
P / B39.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -83.4% | -102.1% | -116.0% | -93.5% | -193.6% |
| Return on equity | -143.6% | -195.6% | -182.4% | -134.2% | 117.1% |
| Current ratio | 2.38 | 2.09 | 2.75 | 3.30 | 2.41 |
Source: SEC EDGAR filings · CIK 0001875558 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.